Αποτελέσματα Αναζήτησης
25 Νοε 2019 · FRANKFURT/LONDON (Reuters) - European private equity firm CapVest has tapped potential bidders for its French nuclear medicine provider Curium, sources told Reuters, aiming for a deal that values...
25 Απρ 2024 · Use the symbol finder to find stocks, funds, and other assets. The Dividend History page provides a single page to review all of the aggregated Dividend payment information.
Founders Renaud Dehareng. Operating StatusActive. Legal NameCurium Holding France S.A.S. Company TypeFor Profit. Phone Number+33 1 69 85 76 76. Curium is a world-class nuclear medicine solutions provider with over 100 years of industry experience.
1 Ιαν 2021 · Information on valuation, funding, acquisitions, investors, and executives for Curium Pharma (Paris). Use the PitchBook Platform to explore the full profile.
See insights on Curium including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
See Curium funding rounds, investors, investments, exits and more. Evaluate their financials based on Curium's post-money valuation and revenue.
Curium is a global leader in the field of nuclear medicine. The company's primary offerings include the development, manufacturing, and distribution of radiopharmaceutical products, which are used in the diagnosis and treatment of various diseases.
